|
 Improve positive, negative symptoms and cognitive function.
Reduce incidence of suicide, violence, and aggression.
Positive response in patients that did not respond to other antipsychotics. |
|
|
|
50% less expensive.
70% less expensive than Olanzapine.
100% discount on PAMI and IOMA.
PAD program, for high dose patients, assuring low monthly costs. |
|
|
|
Due to the support the In Depth Drug Safety Program offers.
Due to follow up and patient monitoring.
Due to permanent comprehensive evaluation and in hematologic emergencies. |
|
